Raltegravir and Atazanavir Replacing Current Suppressive Treatment Because of Side Effects in Current Treatment
Status:
Unknown status
Trial end date:
2009-12-01
Target enrollment:
Participant gender:
Summary
Subjects with HIV who have viral suppression on current regimen but also have side
effects/intolerance will change their current regimen to a combination of Raltegravir and
Atazanavir and be monitored for viral and immunological response and quality of life.